Michel Bouvier

发表

GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge Base

George Khelashvili, Kevin C. Dorff, Jufang Shan, 2010, Bioinform..

TWENTY QUESTIONS: THE STATE OF GPCR RESEARCH IN 2004

Michel Bouvier, Susan R. George, T. Bartfai, 2004 .

Requirements and ontology for a G protein-coupled receptor oligomerization knowledge base

Michel Bouvier, Susan R. George, Jonathan A. Javitch, 2007, BMC Bioinformatics.

Author Correction: Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response

Olivier Lichtarge, Michel Bouvier, Besma Benredjem, 2020, Nature Communications.

Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization

Francesca Fanelli, Michel Bouvier, Luigi F Agnati, 2003, Journal of Biological Chemistry.

Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region

A. J. Venkatakrishnan, Gebhard F. X. Schertler, M. Madan Babu, 2016, Nature.

Functional Significance of Oligomerization of G-protein-coupled Receptors

Michel Bouvier, S. Angers, M. Bouvier, 2000, Trends in Endocrinology & Metabolism.

A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation*

Michel Bouvier, D. Bichet, M. Bouvier, 1996, The Journal of Biological Chemistry.

Pharmacological chaperones: potential treatment for conformational diseases

Michel Bouvier, D. Bichet, M. Bouvier, 2004, Trends in Endocrinology & Metabolism.

Oligomerization of Transcriptional Intermediary Factor 1 Regulators and Interaction with ZNF74 Nuclear Matrix Protein Revealed by Bioluminescence Resonance Energy Transfer in Living Cells*

Michel Bouvier, M. Bouvier, Delphine Germain-Desprez, 2003, Journal of Biological Chemistry.

Real-time monitoring of receptor and G-protein interactions in living cells

Michel Bouvier, Céline Galés, M. Bouvier, 2005, Nature Methods.

Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059.

Michel Bouvier, D. Bichet, M. Bouvier, 2004, Molecular endocrinology.

Restructuring G-Protein- Coupled Receptor Activation

Michel Bouvier, M. Bouvier, Martin Audet, 2012, Cell.

Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.

Michel Bouvier, D. Bichet, M. Bouvier, 2005, Journal of the American Society of Nephrology : JASN.

Multiplexing of multicolor bioluminescence resonance energy transfer.

Michel Bouvier, Christian Le Gouill, M. Bouvier, 2010, Biophysical journal.

Quantitative Assessment of β1- and β2-Adrenergic Receptor Homo- and Heterodimerization by Bioluminescence Resonance Energy Transfer*

Jean-François Mercier, Michel Bouvier, J. Mercier, 2002, The Journal of Biological Chemistry.

Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns.

Michel Bouvier, M. Bouvier, Sonia Terrillon, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET).

Michel Bouvier, Ali Salahpour, Stephane Angers, 2000 .

Real-time monitoring of ubiquitination in living cells by BRET

Michel Bouvier, Pascale G. Charest, Julie Perroy, 2004, Nature Methods.

Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.

Michel Bouvier, S. Angers, M. Bouvier, 2002, Annual review of pharmacology and toxicology.

Structural and functional aspects of G protein-coupled receptor oligomerization.

Michel Bouvier, Terence E. Hébert, 1998 .

Simultaneous Activation of the δ Opioid Receptor (δOR)/Sensory Neuron-Specific Receptor-4 (SNSR-4) Hetero-Oligomer by the Mixed Bivalent Agonist Bovine Adrenal Medulla Peptide 22 Activates SNSR-4 but Inhibits δOR Signaling

Michel Bouvier, Lakshmi A. Devi, M. Bouvier, 2006, Molecular Pharmacology.

Development and Characterization of Pepducins as Gs-biased Allosteric Agonists*♦

Michel Bouvier, Reynold A Panettieri, B. Kobilka, 2014, The Journal of Biological Chemistry.

International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers

Michel Bouvier, Lakshmi Devi, Jonathan A. Javitch, 2007, Pharmacological Reviews.

Quantification of Ligand Bias for Clinically Relevant β2-Adrenergic Receptor Ligands: Implications for Drug Taxonomy

Arthur Christopoulos, Michel Bouvier, A. Christopoulos, 2014, Molecular Pharmacology.

Probing the activation-promoted structural rearrangements in preassembled receptor–G protein complexes

Michel Bouvier, Céline Galés, Yann Percherancier, 2006, Nature Structural &Molecular Biology.

Methods to monitor the quaternary structure of G protein‐coupled receptors

Michel Bouvier, Graeme Milligan, G. Milligan, 2005, The FEBS journal.

Insights into signaling from the beta2-adrenergic receptor structure.

Michel Bouvier, M. Bouvier, Martin Audet, 2008, Nature chemical biology.

Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction.

Michel Bouvier, Céline Galés, Yann Percherancier, 2008, The Journal of biological chemistry.

Evolutionary action and structural basis of the allosteric switch controlling β2AR functional selectivity

Angela D. Wilkins, Olivier Lichtarge, Michel Bouvier, 2017, Nature Communications.

Building a new conceptual framework for receptor heteromers.

Michel Bouvier, Graeme Milligan, Jonathan A Javitch, 2009, Nature chemical biology.

Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer.

Jean-François Mercier, Michel Bouvier, J. Mercier, 2002, The Journal of biological chemistry.

A Synthetic Biology Approach Reveals a CXCR4-G13-Rho Signaling Axis Driving Transendothelial Migration of Metastatic Breast Cancer Cells

Michel Bouvier, Hiroshi Yagi, J Silvio Gutkind, 2011, Science Signaling.

Homodimerization of the β2-Adrenergic Receptor as a Prerequisite for Cell Surface Targeting*

Jean-François Mercier, Michel Bouvier, J. Mercier, 2004, Journal of Biological Chemistry.

Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation.

Michel Bouvier, S. Marullo, M. Bouvier, 2005, Trends in pharmacological sciences.

Oligomerization of G-protein-coupled transmitter receptors

Michel Bouvier, M. Bouvier, 2001, Nature Reviews Neuroscience.

Simultaneous activation of the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling.

Michel Bouvier, Lakshmi A Devi, M. Bouvier, 2006, Molecular pharmacology.

Bioluminescence Resonance Energy Transfer Reveals Ligand-induced Conformational Changes in CXCR4 Homo- and Heterodimers*

Michel Bouvier, Yann Percherancier, Hirokazu Tamamura, 2005, Journal of Biological Chemistry.

Constitutive Agonist-independent CCR5 Oligomerization and Antibody-mediated Clustering Occurring at Physiological Levels of Receptors* 210

Michel Bouvier, Marc Parmentier, M. Parmentier, 2002, The Journal of Biological Chemistry.